Nephros (NEPH) Operating Leases (2019 - 2026)

Nephros' Operating Leases history runs 8 years deep, the most recent figure standing at $566000.0 for Q1 2026.

• In Q1 2026, Operating Leases fell 41.59% year-over-year to $566000.0; the TTM figure through Mar 2026 stood at $566000.0 (down 41.59% YoY), while the FY2025 annual figure was $672000.0, down 36.78% from the prior year.
• Operating Leases was $566000.0 for Q1 2026 at Nephros, down from $672000.0 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $1.4 million in Q4 2023 to a low of $201000.0 in Q3 2022.
• Historically, Operating Leases has averaged $777941.2 across 5 years, with a median of $705000.0 in 2022.
• The sharpest annual moves came in 2024 and 2026: Operating Leases soared 146.06% in 2024, then sank 41.59% in 2026.
• A 5-year view of Operating Leases shows it stood at $705000.0 in 2022, then soared by 97.16% to $1.4 million in 2023, then dropped by 23.53% to $1.1 million in 2024, then sank by 36.78% to $672000.0 in 2025, then decreased by 15.77% to $566000.0 in 2026.
• The last three Operating Leases figures came in at $566000.0 (Q1 2026), $672000.0 (Q4 2025), and $774000.0 (Q3 2025), per Business Quant data.